Centre likely to take the auction route to divest stake in Dredging Corporation

PTI New Delhi | Updated on January 12, 2018

The government think tank NITI Aayog too has favoured disinvestment, which could fetch around ₹1,400 cr to the exchequer

Plans are afoot to sell holding in four unlisted firms too

The government is planning an outright sale of Dredging Corporation of India (DCIL) through auction, which could fetch about ₹1,400 crore to the exchequer.

Besides, there is a proposal to sell 100 per cent government holding in four unlisted companies — Kamarajar Port, HLL Lifecare, Indian Medicines & Pharmaceutical Corporation and Karnataka Antibiotics and Pharmaceuticals.

According to sources, the core group of secretaries on disinvestment, headed by the Cabinet Secretary, has already approved the sale of these five companies.

The government think-tank NITI Aayog too has favoured disinvestment.

An approval of the Cabinet Committee Economic Affairs (CCEA) would be sought soon, sources said.

The government currently holds 73.47 per cent stake in Dredging Corporation of India (DCIL). At the current market prices, sale of this stake would fetch about ₹1,400 crore to the exchequer.

Two-stage auction

The government is also mulling a two-stage auction process for the PSU, which made a net profit of ₹7.40 crore in 2016-17 fiscal.

The stages will entail shortlisting of eligible bidders and competitive financial bidding.

Also, the CCEA is likely to consider an improved voluntary retirement scheme (VRS) along with the process of sale of the profit-making PSU.

Since dredging is not a strategic sector, the government is considering to exit the Miniratna PSU by selling it to private players.

With regard to Kamarajar Port, the government is looking to divest 100 per cent of its holding and is considering valuation methodology such as discounted cash flow, asset valuation and relative valuation.

For HLL Lifecare, the proposal entails hiving off the CPSEs vaccine venture and Medipark into two separate special purpose vehicles. After that, the government could look at 100 per cent stake sale in the company.

The assets of Indian Medicines & Pharmaceutical Corp and Karnataka Antibiotics and Pharma, according to sources, are likely to be valued at a mix of discounted cash flow, relative valuation and asset-based valuation.

The government has budgeted to raise ₹15,000 crore through strategic sale of PSUs this fiscal.

Published on June 18, 2017

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor